JAN 05, 2017 3:22 PM PST

Compound Blocks Melanoma Metastasis by 90 Percent

WRITTEN BY: Xuan Pham

A large portion of melanoma cases prove fatal because the disease has already progressed beyond treatment options. However, a new study reports that a small-molecule drug can stop the spread of melanoma by as much as 90 percent. Furthermore, the pathway behind this drug’s actions may be developed into a useful biomarker to identify and successfully treat melanoma patients in the early stages.

"Melanoma is the most dangerous form of skin cancer with around 76,000 new cases a year in the United States," said Kate Appleton, co-author of the study, published in Molecular Cancer Therapeutics. "One reason the disease is so fatal is that it can spread throughout the body very quickly and attack distant organs such as the brain and lungs."

To fight the spread of melanoma, Appleton and her colleagues turned to a small molecule drug that showed promise against another skin-related disease known as scleroderma.

"It's been a challenge developing small-molecule drugs that can block this gene activity that works as a signaling mechanism known to be important in melanoma progression," said Richard Neubig, a pharmacology professor and the study’s senior author. "Our chemical compound is actually the same one that we've been working on to potentially treat the disease scleroderma, which now we've found works effectively on this type of cancer." Scleroderma is a autoimmune rheumatic disease that hardens the skin and affects other vital organs.

In particular, Neubig and his team reported that treatment of this compound seemed to stop melanoma’s spread by 85 to 90 percent. Mice injected with melanoma cells also showed smaller tumors with exposure to this drug.

They credit the anticancer effects to the molecule’s ability to inhibit a protein known as Myocardin-related transcription factor (MRTF). This protein normally initiates genetic transcription in cancer cells. Blocking it may prevent the spread of aggressive melanoma throughout the body.

Importantly, the anticancer effects of this compound was most significant in melanomas with this pathway activated. "The effect of our compounds on turning off this melanoma cell growth and progression is much stronger when the pathway is activated," Appleton explained. This knowledge could be applied towards the development of diagnostic tests to detect early melanoma presence as well as identify patients who would best respond to the drug. "We could look for the activation of the MRTF proteins as a biomarker to determine risk, especially for those in early-stage melanoma."

"The majority of people die from melanoma because of the disease spreading," said Neubig. "Our compounds can block cancer migration and potentially increase patient survival." Neubig stressed that, for melanoma, early detection and treatment is key, as the mortality rate rises from 2 percent if the disease is caught early versus a staggering 84 percent if the disease is caught late.

Additional sources: Michigan State University

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
APR 08, 2021
Cancer
What can modifiying cultured cells to act more like normal cells teach us about cancer?
APR 08, 2021
What can modifiying cultured cells to act more like normal cells teach us about cancer?
A team from the University of Louisville has developed a technique to make cell cultures act more like normal cells. Thi ...
APR 19, 2021
Health & Medicine
Using Artificial Intelligence to Understand the Language of Cancer and Alzheimer's Disease
APR 19, 2021
Using Artificial Intelligence to Understand the Language of Cancer and Alzheimer's Disease
Cancer and Alzheimer’s disease are life-changing, and there is still much we don’t understand about what cau ...
MAY 04, 2021
Clinical & Molecular DX
Vibrating Needles Make for Better Biopsies
MAY 04, 2021
Vibrating Needles Make for Better Biopsies
  To understand what’s going on with a patient, doctors may take a biopsy—a sample of tissue extracted ...
MAY 26, 2021
Genetics & Genomics
Connecting Bacterial Genes to Human Disease
MAY 26, 2021
Connecting Bacterial Genes to Human Disease
This kind of research gets us closer to using fecal samples to get a snapshot of the microbiome, and make disease risk p ...
JUL 22, 2021
Cell & Molecular Biology
Cancer Cells in the Lab Aren't Like Cancer Cells in the Body
JUL 22, 2021
Cancer Cells in the Lab Aren't Like Cancer Cells in the Body
To study biology, researchers need models. Once those models might have been a bit limited to organisms like rats or mic ...
JUL 23, 2021
Cancer
Repurposed Antibiotics Show Promise Against Skin Cancer
JUL 23, 2021
Repurposed Antibiotics Show Promise Against Skin Cancer
In experiments with mice, researchers from the Netherlands have found that some antibiotics may be effective in tre ...
Loading Comments...